ArticleViruses2026

Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025.

Lauren Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.